Skip to Main Content

Author Details

Emily A Stevens
Clinical Research Division, Fred Hutchinson Cancer Research Center
2005
14
11
PMIDPaper TitleJournal TitlePublished Year
30962501Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis.Bone Marrow Transplant2020
32817791AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.Biomark Res2020
32194289Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation.Biol Blood Marrow Transplant2020
31366621Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.Blood2019
28970176Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.Biol Blood Marrow Transplant2018
29274396Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.Biol Blood Marrow Transplant2018
28091601Massively parallel digital transcriptional profiling of single cells.Nat Commun2017
26475333The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.Clin Cancer Res2016
25042935Genomic medicine and targeted therapy for solid tumors.J Surg Oncol2015
19538249The aryl hydrocarbon receptor: a perspective on potential roles in the immune system.Immunology2009
18451850Immunology: T cells hang in the balance.Nature2008
16354765The teratogenic sensitivity to 2,3,7,8-tetrachlorodibenzo-p-dioxin is modified by a locus on mouse chromosome 3.Mol Pharmacol2006
16582008The aryl hydrocarbon receptor signaling pathway is modified through interactions with a Kelch protein.Mol Pharmacol2006
15668235Transforming growth factor-beta3 restores fusion in palatal shelves exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.J Biol Chem2005
  • 1 - 14 of 14

Recommended Authors

Pavana Anur
Oregon Health & Science University
Career Start Year 2009
Number of shared co-authors 3
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 2
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 31
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 4
Evan F Lind
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 23
David M Weinstock
Merck & Co.
Career Start Year 1998
Number of shared co-authors 8
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 5
Angela G Fleischman
University of California Irvine
Career Start Year 1998
Number of shared co-authors 16
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 6
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 2
Lucy A Godley
The University of Chicago
Career Start Year 1994
Number of shared co-authors 9
Jean Soulier
University of Paris
Career Start Year 1993
Number of shared co-authors 2
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 9
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 3
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 8
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 0
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 1
Brent W Zanke
University of Toronto
Career Start Year 1987
Number of shared co-authors 1
Kim E Nichols
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 3
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 4
Toshio Kitamura
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Timothy J Ley
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 3
Paul Brent Ferrell
Vanderbilt University
Career Start Year 1981
Number of shared co-authors 1
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 26
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 9
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Career Start Year 1974
Number of shared co-authors 1
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 0

Collaborators

Jerald P Radich
Fred Hutchinson Cancer Center
Co-authored papers 4
Jason Gotlib
Stanford University School of Medicine
Co-authored papers 2
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 2
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Samantha L Savage
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Brian J Druker
Oregon Health & Science University
Co-authored papers 1
David Wu
University of Washington
Co-authored papers 1
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 1
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 1
Robert P Searles
Oregon Health & Science University
Co-authored papers 1
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 1
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 1
Daniel J DeAngelo
Dana-Farber Cancer Institute
Co-authored papers 1
Hein Than
Singapore General Hospital
Co-authored papers 1
Soheil Meshinchi
Fred Hutchinson Cancer Research Centre
Co-authored papers 1
Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Tarjei S Mikkelsen
Harvard University, USA Broad Institute, USA Harvard Stem Cell Institute
Co-authored papers 1
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers 1
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Effie W Petersdorf
Fred Hutchinson Cancer Center
Co-authored papers 1
Stephen T Oh
Washington University School of Medicine
Co-authored papers 1
Rachel Henson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Co-authored papers 1
Bruno C Medeiros
AbbVie Inc.
Co-authored papers 1
Beth Wilmot
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Vishesh Khanna
Stanford University School of Medicine
Co-authored papers 1
Amy Carlos
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Libbey White
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Release 1.2